Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Significance of Germline BRCA Mutations

NCT00579488 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00579488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00579488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Significance of Germline BRCA Mutations
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
July 31, 1996
Completion date
July 31, 2027
Enrollment
13,320 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ovarian cancer